ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673421 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673421; 2) Community: the network communities that were significantly associated with the response to NSC 673421; 3) Molecule: the relationships between components within communities and NSC 673421; 4) MDR: the compounds that were significantly associated with the NSC 673421.

NSC Compound Enrichment Correlation
NSC 278632 Null 0.038506707102734 0.30735842
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.038506707102734 0.31226257
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.038506707102734 0.34815753
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.038506707102734 0.52107337
NSC 609695 bis(3-chloropropyl) disulfide, S,S-dioxide 0.038506707102734 0.5450357
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.038506707102734 0.49705704
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.038506707102734 0.4128218
NSC 622282 4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- 0.038506707102734 0.41123801
NSC 623436 TGF.alpha.-PE40 0.038506707102734 -0.32850008
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.038506707102734 0.54210452
Total:103  Current:69    [First] [Prev] [Next] [Last]